US Patent 10029116 Method for the treatment of acne

Patent 10029116 was granted and assigned to DUSA Pharmaceuticals on July, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

DUSA Pharmaceuticals

Current Assignee

DUSA Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10029116

Date of Patent

July 24, 2018

Patent Application Number

15207405

Date Filed

July 11, 2016

Patent Primary Examiner

‌

Ahmed Farah

Patent abstract

This application is directed to a method of treating a patient with acne by applying a photodynamic agent to skin having acne lesions, waiting at least 12 hours, and then exposing the skin to which the photodynamic agent has been applied to light that causes an activation reaction.